Related Experiment Video
Updated: Jun 2, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Analysis of drug interactions.
Irene V Bijnsdorp1, Elisa Giovannetti, Godefridus J Peters
1Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands. IV.Bijnsdorp@vumc.nl
Methods in Molecular Biology (Clifton, N.J.)
|April 26, 2011
Summary
Empirically designed drug combinations are common in cancer and other therapies. This study explores in vitro combination design and analysis using Calcusyn/Compusyn to identify synergistic, additive, or antagonistic effects.
Area of Science:
- Pharmacology
- Biotechnology
- Computational Biology
Background:
- Current cancer, immune, and viral therapies often rely on empirically designed drug combinations.
- These combinations aim to enhance therapeutic effects, reduce side effects, and prevent drug resistance by targeting multiple pathways.
- However, rigorous experimental exploration of drug combinations and their interactions is often lacking.
Purpose of the Study:
- To describe methods for designing and analyzing drug combinations in vitro.
- To evaluate the effectiveness of drug combinations using quantitative methods.
- To highlight the utility and limitations of Calcusyn and Compusyn software for combination analysis.
Main Methods:
- In vitro design of drug combinations with varying schedules (simultaneous, sequential).
- Quantitative analysis of dose-effect relationships for single agents and combinations.
- Utilizing median-drug effect analysis and calculating a Combination Index (CI) using Calcusyn or Compusyn software.
Main Results:
- The study details the process of in vitro drug combination design and analysis.
- It explains how to interpret Combination Index (CI) values to determine synergism, additivity, or antagonism.
- Potential pitfalls, limitations, and advantages of the described methods and software are discussed.
Conclusions:
- Systematic in vitro analysis is crucial for optimizing drug combinations before clinical evaluation.
- Software like Calcusyn and Compusyn provides valuable tools for quantitative assessment of drug interactions.
- Improved understanding of drug interactions can lead to more effective combination therapies with reduced antagonism.
Related Concept Videos
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:14Agonism and Antagonism: Quantification
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:30Combined Effects of Drugs: Antagonism
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.